Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

No cure for female pattern hair loss, but various effective treatments exist.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

New treatments for PCOS focus on managing symptoms and improving fertility.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Finasteride increases hair count and improves hair growth with low risk of side effects.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Alternative treatments show promise for hair growth beyond traditional methods.

Hair restoration surgery redistributes existing hair to achieve a natural look, with visible regrowth in 3-4 months and rare complications, mostly aesthetic.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.